Navigation Links
Thomson Reuters Commemorates World IP Week with Series of Strategic Intellectual Property Seminars Across the U.S.
Date:4/23/2009

Experts from AT&T, Caterpillar, Dechert LLP, General Electric, and Townsend & Townsend & Crew LLP convene to share IP strategies and best practices at "The New Age of Intelligent IP" seminars

PHILADELPHIA, April 23 /PRNewswire/ -- The IP Solutions business of Thomson Reuters commemorates World IP Week, April 26 - May 1, 2009, with a series of strategic intellectual property seminars in San Francisco, Chicago and Philadelphia titled "The New Age of Intelligent IP." The seminars provide valuable insight on the impact of the economic climate on intellectual property, the rise of patenting in China and its effect on U.S. businesses, and best practice methodologies for managing IP rights throughout the Intellectual Property Lifecycle. Agendas and more information can be found at http://ip.thomsonreuters.com/seminars/.

"As a leader in intellectual property solutions, Thomson Reuters thought it appropriate to host our North American IP Seminars during World IP Week, to show our commitment to and focus on promoting intellectual property as a critical component of an organization's business strategy," said Michael Thompson, director of marketing, IP Solutions, Thomson Reuters. "The events offer a unique opportunity for IP professionals to learn valuable strategies and best practices, while networking with leaders within this space."

Each seminar is one full day, running from 8:30 a.m. - 6:00 p.m. at each respective location:

  • San Francisco: The Mark Hopkins Intercontinental Hotel, One Nob Hill, San Francisco
  • Chicago: The Four Seasons Hotel, 120 East Delaware Place, Chicago
  • Philadelphia: The Ritz Carlton, Ten Avenue of the Arts, Philadelphia

In addition to Thomson Reuters management, guest speakers from the industry will also give presentations at these seminars. Guest speakers include:

  • Anthony Trippe, 3LP Advisors
  • John Rollins, Accenture
  • Jeffrey Farah, Ph.D., AT&T
  • Steve Sampson, Caterpillar Inc.
  • Nicky Espinosa, Dechert LLP
  • Thomas Marlow, Fairchild Semiconductor
  • Keith Dilley, General Electric
  • Scott Forbes, Ph.D., General Electric
  • Barry Brager, Perception Partners
  • Patrick Jewik, Townsend & Townsend & Crew LLP
  • Hal Fullmer, Woodcock Washburn

To register for these free events or learn more, go to: http://ip.thomsonreuters.com/seminars/.

Thomson Reuters

Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, scientific, healthcare and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs more than 50,000 people in 93 countries. For more information, go to thomsonreuters.com.


'/>"/>
SOURCE Thomson Reuters
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. APS Healthcare and Thomson Reuters to Manage New York States Medicaid Clinical Best Practices Review Program
2. Thomson Reuters Names Hottest Researchers and Papers of 2007-2008
3. Despite Decline in Share of Global Output, U.S. Science Impact Still Strong, Says Thomson Reuters
4. The National Cancer Institute Joins the Global Community of Scientists Now Using BIOMARKERcenter From Thomson Reuters
5. The Scientific Business of Thomson Reuters Publishes Its 2008 Liquent Regulatory Affairs Trends Survey Results
6. Thomson Reuters Launches New Biomarkers Solution
7. Thomson Scientific Begins Expansion of Web of Science
8. Thomson Scientific Salutes Nobel Laureate Prize Winners, Many of Whom Were Selected as Thomson Scientific Laureates in 2006
9. Thomson Scientific Publishes Who Is Making The Biggest Splash? - A Quarterly Review of Scientific Literature on Drugs and Therapies From April - June 2007
10. Thomson Scientific to Host Pharmaceutical Vision - A Users Conference for Information, Regulatory Affairs, Competitive Intelligence and Biotechnology Professionals
11. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at BioCentury-Thomson Financial Investment Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... 27, 2017 A Europe-wide survey of institutes ... using animals in their research treat them with due care. The ... detailed analysis of the results indicates that there is a strong ... put into practice the principles of the 3Rs (Refine, Reduce, ... What are ...
(Date:2/27/2017)... REDWOOD CITY, Calif. , Feb. 27, 2017 ... specialty pharmaceutical company focused on the development and ... moderate-to-severe acute pain, announced today the U.S. Food ... New Drug Application (NDA) under section 505(b)(2) for ... for the treatment of patients with moderate-to-severe acute ...
(Date:2/27/2017)... HAMILTON, Bermuda , Feb. 27, 2017 /PRNewswire/ ... ) and SELLAS Life Sciences Group , ... immunotherapies, today announced that Advaxis has granted SELLAS ... agent using Advaxis, proprietary Lm -based antigen ... peptide antigen mixture (galinpepimut-S). Advaxis, ...
(Date:2/27/2017)... URBANDALE, Iowa (PRWEB) , ... February 27, 2017 , ... ... is following the advice of his grandfather, “Hire for attitude. Train for skill.” , ... State University star linebacker Jevohn Miller as a salesman. Zamzow is hoping to replicate ...
Breaking Biology Technology:
(Date:2/24/2017)... BARCELONA, Spain , Feb. 24, 2017  EyeLock LLC, ... will demonstrate its elite iris biometric solution on ... with X16 LTE at Mobile World Congress ... in Qualcomm,s Booth in Hall 3, Stand ... contains the Qualcomm Haven™ security platform—a combination ...
(Date:2/16/2017)...  Genos, a community for personal genetic discovery ... Laboratory Accreditation from the College of American Pathologists ... that meet stringent requirements around quality, accuracy and ... "Genos is committed to maintaining the highest ... to be receiving CAP accreditation," said Jill ...
(Date:2/10/2017)... Research and Markets has announced the addition of ... Commercial Aspects" to their offering. ... Biomarkers play an important ... selection of treatment as well for monitoring the results. There ... modern medicine. Biochip/microarray technologies and next generation sequencing are also ...
Breaking Biology News(10 mins):